Korro Bio Common Stock share price logo

Korro Bio Common Stock

NASDAQ: KRRO

Small Cap

$13.71

-0.19

(-1.37%)

as on

Korro Bio Common Stock Stock Performance

as on June 24, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $13.52
    $14.48
    downward going graph

    1.39%

    Downside

    5.62%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.20
    $55.89
    downward going graph

    62.04%

    Downside

    307.66%

    Upside

    downward going graph

Korro Bio Common Stock share price movements today

Previous Close
$13.90
Open
$13.52
Volume
595.3K
Day's Low - High
$13.52 - $14.48
52 Week Low - High
$5.20 - $55.89

Korro Bio Common Stock Historical Returns

1 Month Return
+ 18.09 %
3 Month Return
+ 29.58 %
1 Year Return
+ 8.04 %
3 Year Return
0 %
5 Year Return
0 %

Korro Bio Common Stock Stock Fundamentals & Key Indicators

Check Korro Bio Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$200.5M

EPS (TTM)

-5.1789

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-79.3M

Revenue (TTM)

3.8M

Profit Margin

0.00%

Return On Equity TTM

-87.78%

Korro Bio Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Korro Bio Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$200.5MNANA0.00%NA
BUY$38.2B65.93%71.9612.55%NA
BUY$118.5B144.05%27.735.51%NA
BUY$64.2B13.51%14.9529.65%0.59%

Stock Returns calculator for Korro Bio Common Stock Stock including INR - Dollar returns

The Korro Bio Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Korro Bio Common Stock investment value today

Current value as on today

₹1,19,001

Returns

₹19,001

(+19%)

Returns from Korro Bio Common Stock Stock

₹8,038 (+8.04%)

Dollar Impact

₹10,964 (+10.96%)

Analyst Recommendation on Korro Bio Common Stock Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Korro Bio Common Stock. Average target price of $20

Korro Bio Common Stock Share Price Target

Get share price movements and forecasts by analysts on Korro Bio Common Stock.

What analysts predicted

31.45%UPSIDE

Target Price

$20

Current Price

$13.71

Analyzed by

10 Analysts

Target

$20.00

Korro Bio Common Stock target price $20, a slight upside of 31.45% compared to current price of $13.71. According to 10 analysts rating.

Indian Investors' Interest in Korro Bio Common Stock Stock

Search interest for Korro Bio Common Stock Stock has increased by 39% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:39% versus previous 30 day period

Korro Bio Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
2
2
1
1
1
-
Gross Profit
-1
0
0
0
2
2
1
1
0
0
Operating Income
-26
-21
-24
-23
-23
-25
-27
-19
-15
-20
EBITDA
-25
-20
-23
-22
-21
-23
-25
-16
-15
-20
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
1
1
1
1
0
0
Income Before Tax
-25
-19
-21
-21
-21
-23
-25
-18
-49
-19
Income Tax Expense
0
0
0
0
0
-
0
-
0
0
Net Income
-25
-19
-21
-20
-21
-23
-25
-18
-50
-19
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-933.47%
-917.14%
-1765.07%
-1656.97%
-3873.22%
0.00%

Korro Bio Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
28
36
14
-
-
2
6
Gross Profit
12
35
10
-2
-3
2
2
Operating Income
-20
-27
-84
-58
-84
-91
-87
EBITDA
-17
-24
-80
-56
-80
-88
-83
Interest Expense
-
-
0
0
-
-
-
Depreciation
-
-
1
2
3
3
4
Income Before Tax
-18
-26
-84
-58
-81
-83
-116
Income Tax Expense
-
0
0
0
0
0
0
Net Income
-18
-26
-84
-58
-81
-83
-117
Net Profit Margin
-64.76%
-71.68%
-601.98%
0.00%
0.00%
-3680.36%
-1834.48%

Korro Bio Common Stock Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-19
-21
-20
-21
-23
-25
-18
-50
-19
Operating Cash Flow
-21
-14
-16
-7
-24
-19
-17
-17
-16
Investing Cash Flow
-5
-102
-12
-2
32
-11
7
14
-32
Financing Cash Flow
0
67
0
0
0
0
0
0
88
Change in Cash
-27
-49
-27
-9
8
-29
-9
-2
39

Korro Bio Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-19
-18
-10
-21
-58
-81
-83
-117
Operating Cash Flow
-17
34
-45
-32
-53
-67
-60
-78
Investing Cash Flow
3
-18
10
-39
11
11
-123
43
Financing Cash Flow
37
142
56
115
0
187
69
0
Change in Cash
24
157
20
44
-42
131
-114
-33

Global Institutional Holdings in Korro Bio Common Stock

Funds
Holdings
Adage Capital Partners Gp LLC
1.58%
Vanguard Portfolio Management, LLC
1.03%
Jane Street Group LLC
2%
Renaissance Technologies Corp
0.94%
Atlas Venture Life Science Advisors, LLC
7.88%

Insights on Korro Bio Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, KRRO stock has moved up by 24.1%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, KRRO has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 18.3% return, outperforming this stock by 10.3%

About Korro Bio Common Stock

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
OrganisationKorro Bio Common Stock
Headquarters60 First Street, Cambridge, MA, United States, 02141
IndustryBiotechnology
CEODr. Ram Aiyar MBA, Ph.D.
E-voting on sharesClick here to vote

Key Management of Korro Bio Common Stock

Name

Title

Ms. Stephanie Engels

Chief People Officer

Dr. Gaozhong Zhu Ph.D.

SVP of Chemistry, Manufacturing and Controls & Technical Operations

Dr. Ram Aiyar MBA, Ph.D.

CEO, President, Interim CFO, Principal Financial Officer & Director

Dr. Loic Vincent Ph.D.

Chief Scientific Officer

Dr. Andrew Fraley Ph.D.

Co-Founder & Advisor

Mr. Todd Chappell M.B.A.

Chief Operating Officer

Dr. Jeffrey M. Cerio J.D., Pharm.D.

Senior VP, General Counsel & Corporate Secretary

Dr. Joshua Rosenthal Ph.D.

Co-Founder & Advisor

Mr. Oliver Dolan

Senior VP of Finance & Principal Accounting Officer

FAQs

What is Korro Bio Common Stock share price today?

Korro Bio Common Stock share price today is $13.71 as on at the close of the market. Korro Bio Common Stock share today touched a day high of $14.48 and a low of $13.52.

What is the 52 week high and 52 week low for Korro Bio Common Stock share?

Korro Bio Common Stock share touched a 52 week high of $55.89 on and a 52 week low of $5.2 on . Korro Bio Common Stock stock price today i.e. is closed at $13.71,which is 75.47% down from its 52 week high and 163.43% up from its 52 week low.

What is Korro Bio Common Stock's market capitalisation today?

Korro Bio Common Stock market capitalisation is $0.00T as on .

How to invest in Korro Bio Common Stock Stock (KRRO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Korro Bio Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Korro Bio Common Stock Shares that will get you 0.1094 shares as per Korro Bio Common Stock share price of $13.71 per share as on June 24, 2026 at 8:46 am IST.

What is the minimum amount required to buy Korro Bio Common Stock Stock (KRRO) from India?

Indian investors can start investing in Korro Bio Common Stock (KRRO) shares with as little as ₹94.665 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.65 in Korro Bio Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Korro Bio Common Stock share’s latest price of $13.71 as on June 24, 2026 at 8:46 am IST, you will get 0.7294 shares of Korro Bio Common Stock. Learn more about fractional shares .